News Releases

Virtual Phantoms has reseller agreements in China and Japan

Posted on Apr 5, 2018

Interested customers in China and Japan now have local partners to contact to inquire about purchase of subscriptions to VirtualDose!  By engaging with local distributors, customers can access the same VirtualDose product, but be able to interact with trusted companies that understand the local market and can provide fast and understandable front-line support.  Visit their websites to learn more!  ...

read more

See VirtualDose at RSNA 2017

Posted on Nov 22, 2017

Virtual Phantoms Chief Technology Officer, Dr. Peter Caracappa, will be at the RSNA 2017 meeting in Chicago, IL, and available for demonstrations of the industry-leading VirtualDoseCT, and the newly released VirtualDoseIR. Set up your appointment to see the tools in action, and get a preview of some exciting new upcoming features! Arrange appointments by email: sales@virtualphantoms.com. See you in...

read more

Virtual Phantoms, Inc Announces the Release of VirtualDose-IR, a New Tool For Organ Dose Data from Interventional Radiology Procedures

Posted on Jul 31, 2017

(31st July 2017)  —Virtual Phantoms, Inc of Albany, NY USA today announced the release of VirtualDoseIR, a tool for assessing organ dose from Interventional Radiology procedures.  Like its industry-leading product for computed tomography, VirtualDoseCT, VirtualDoseIR combines a family of anatomically realistic human phantoms, advanced Monte Carlo simulations, and an easy to use web interface to provide realistic calculations of dose to a diverse patient population. Advanced models used for organ dose simulationsVirtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, that has made VirtualDoseCT so successful.  It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, pediatric patients from newborn through adolescence, and patients who are pregnant.   IR – New Tools for a growing trend In recent years, interventional radiology (IR) procedures have expanded beyond the traditional cardiovascular applications to many other specialty areas, and so their overall use has increased significantly, today contributing more than 14% of all medical radiation dose in the US.  Long exposure times can subject patients to acute injuries to the skin and other tissues, but the large accumulated doses pose a long-term radiation risk that can be monitored and managed.  With continued growth, it is likely that regulatory attention will turn to IR in the future.  VirtualDose provides an important tool to understanding and managing IR dose.   “We are very excited to be making this important expansion of the VirtualDose product line.  When we began, CT was far and away received the most attention in terms of patient dose.  In recent years, Interventional Radiology has grown in importance to the point that it has received much more focus,” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc. “We know that VirtualDoseIR will become an invaluable tool for assessing clinical practice of IR and improving patient safety.”   Useful features for clinical application VirtualDoseIR has been designed with clinical practice in mind.  Our web interface allows the user to easily select the parameters of the procedure setup, including field size, kVp, filtration, position, and direction.  As these are selected, the display updates to provide a visualization of the exam field on the patient to ensure it matches the procedure performed.  And because different machines may track different information, the system will accept x-ray output in terms of Dose-Area-Product or air kerma rate and exposure time (both commonly encountered measurements).     Sample display screens from the VirtualDoseIR software   About VPI   Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering. Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling of ionizing radiation, radiation safety, and medical/occupational radiation dosimetry.  For more information about Virtual Phantoms or VirtualDose, visit www.virtualphantoms.com or call or email Peter Caracappa, VPI Chief Technology Officer;  +1...

read more

INFINITT Healthcare and Virtual Phantoms, Inc Announce Partnership to Add Organ Dose Data to DoseM Radiation Dose Monitoring Software

Posted on Jul 25, 2017

(25th July 2017)  — INFINITT Healthcare, of Seoul, Republic of Korea (South Korea), and Virtual Phantoms, Inc of Albany, NY USA announced today that they have entered into a partnership to bring the VirtualDose™CT organ dose tool to the INFINITT radiation dose monitoring solution, DoseM. With this partnership, INFINITT further enhances their software solution for collecting and managing dose data and improving patient safety.         Patient safety in medical imaging is a priority INFINITT DoseM is a web-based radiation dose management system, which automatically extracts, stores, and manages dose information from radiation devices and can be interfaced with hospital information systems (e.g., HIS, EMR, PACS, etc) to make dose information accessible as part of the patient record.  INFINITT DoseM can also automatically collect dose information and manage doses efficiently by using Diagnostic Reference Levels(DRL) information.   Dose tracking has become a high priority in medical imaging as mandates for the capture and analysis of patients’ exposure to ionizing radiation expand. By adding patient organ dose to a tool that enables capture and archiving of dose data from multiple modalities and a variety of vendors, the data necessary for a realistic estimate of cumulative risk from ionizing radiation exposure is finally available. 
   Advanced models are used for organ dose simulations This agreement makes the Virtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, available to INFINITT customers.  It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. The VirtualDoseCT calculation engine integrates seamlessly with the DoseM software, providing improved information without extra effort on the part of the user. “We are very happy INFINITT Healthcare has selected the VirtualDose technology to provide organ dose data and improve patient safety and information.  With this, our first partnership with an Asia-based company, we are growing the global impact of VirtualDoseCT” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc.   Sample display screens from the INFINITT DoseM software   ABOUT INFINITT Healthcare INFINITT Healthcare is a global provider of medical imaging and information systems. Being founded in 2002 and listed on Kosdaq in 2010, the company is driving the advancement of healthcare IT by delivering its award-winning products and services to 5,200+ healthcare institutions in more than 51 countries through its global business units and distributers. In the United States, INFINITT Healthcare products are distributed through INFINITT North America, a wholly-owned subsidiary of INFINITT Healthcare. INFINITT’s enterprise imaging solutions include RIS, PACS, Cardiology Suite, Mammography PACS, Dental PACS and 3D/Advanced Visualization software, all operating on a unified platform. INFINITT PACS has been a category leader in Best in KLAS Awards: Software and Services eight times since 2009: 2009-2012 in the Community Hospital category, 2013 in the Ambulatory category, 2015/2016 in both Community and Ambulatory categories, and in the Community Hospital category again in 2017. For more information, call 877-387-6960 or visit www.infinittna.com.   About VPI Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF...

read more

Visit our Booth #8025 at AAPM 2017

Posted on Jul 18, 2017

Virtual Phantoms will be exhibiting at the American Association of Physicists in Medicine (AAPM) annual meeting in Denver, CO – July 30 – August 3, 2017. Find us in Booth #8025 Dr. Peter Caracappa, Chief Technology Officer, and John Crossin, Chief Operating Officer, will be there to show our products and answer your questions. If you would like to schedule an appointment ahead of time, email peter.caracappa@virtualphantoms.com to set up a time. See you in...

read more

Follow Virtual Phantoms on Facebook, Twitter, LinkedIn

Posted on May 21, 2017

Keep track of the news from Virtual Phantoms through your favorite social media sites!  We have established a presence on Facebook, Twitter, and LinkedIn — follow us with the links below:   Facebook:  Twitter: Follow @VPI_VirtualDose  ...

read more

Medsquare signs a partnership with Virtual Phantoms to add a new module: calculation of the organ dose

Posted on Mar 1, 2017

February 28, 2017 — Medsquare is proud to announce the integration of the organ dose module ‘VirtualDose™CT’ into its DACS Radiation Dose Monitor (RDM) solution. Developed in partnership with Virtual Phantoms, Inc., this new module will be added to RDM’s existing features and will be presented for the first time at the European Congress of Radiology (ECR).   The features of the organ dose module are the following: Monte Carlo algorithm calculation of mean doses delivered to organs by type of activity using existing dose data (DLP, CTDI, etc.) Estimation of the dose received by the fetus from the different stages of gestation of the pregnant woman Several parameters are considered: weight, height, age, pregnancy stages of the pregnant woman, etc. Calculation in accordance with ICRP- 60 and ICRP-103 recommendations “With the calculation of the organ dose, Medsquare is opening a new perspective on patient radiation safety. This agreement − the fruit of over several months of exchanges between the two companies − continues the process of reducing and optimizing the dose delivered to the patient,” said Dominique Gabriel, CEO Medsquare. *DACS: Dose Arching and Communication System   About Virtual Phantoms Inc   Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering. Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling of ionizing radiation, radiation safety, and medical/occupational radiation dosimetry.   For more information about Virtual Phantoms or VirtualDose™CT: Website: www.virtualphantoms.com Contact: Peter Caracappa, VPI Chief Technology Officer; +1 518-421 6931, peter.caracappa@virtualphantoms.com.     About Medsquare   Medsquare provides innovative solutions for the medical imaging environment. Our solutions (burning, printing, archiving, secured web image distribution through the internet, etc.) are currently being used in more than 450 university hospitals and private clinics in France and more than 2000 around the world.   Founded in 2006 as a French company based in Paris, Medsquare is a key partner of the world’s leading radiology equipment manufacturers, who offer our peripheral devices and software to their customers bundled with the sale of their DICOM modalities (CT, MR, XA, etc.).   Medsquare is also a leading player in the DACS (Dose Archiving and Communication System) market. Our patient dose management system – Radiation Dose Monitor (RDM) – enables healthcare institutions to collect, control and analyze radiation doses delivered to patients during medical imaging exams. RDM helps improve clinical practices and optimize doses.   Contact Karen FRANGIE: k.frangie@medsquare.com Communication Leader Medsquare 17 rue du Jura 75013, Paris – France T: + 33 (0)1 55 25 62 50 For more information, visit our website: www.medsquare.com *DACS: Dose Arching and Communication System   PDF Press Release PDF Press Release...

read more

QAELUM Announces Partnership with Virtual Phantoms, Inc to Add Organ Dose Data to Radiation Dose Monitoring Software

Posted on Jan 12, 2017

QAELUM Announces Partnership with Virtual Phantoms, Inc to Add Organ Dose Data to Radiation Dose Monitoring Software (12th January 2017)  — Qaelum NV, of Heverlee, Belgium, and Virtual Phantoms, Inc of Albany, NY USA announced today that they have entered into a partnership to bring the VirtualDose™CT organ dose tool to the Qaelum radiation dose monitoring solution, DOSE. With this partnership, Qaelum further optimizes their software solutions dedicated to patient safety and efficiency in medical imaging.     Patient safety in medical imaging is a priority With increasing awareness of the risk of radiation dose, patient safety is a high priority in medical imaging departments. Radiation dose during medical examination can be optimized and monitored by DOSE, one of the total quality monitoring solutions of Qaelum, a KULeuven spinoff. As the different organs of a human body are of variable dimensions and variable tissue composition, specifying organ radiation dose requires models that take all these variables into account. “We are pleased to announce that advanced organ-dose calculation functionality is now available in DOSE, thanks to partnership with VirtualDoseCT and Virtual Phantoms, Inc.,” said Jurgen Jacobs, CEO of Qaelum NV.  “The inclusion of organ dose is a useful addition to our available metrics for tracking performance and compliance and supporting patient safety, furthering the goal of Total Quality Monitoring that our software provides.”
 Advanced models are used for organ dose simulations This agreement makes the Virtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, available to Qaelum customers.  It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. The VirtualDoseCT calculation engine integrates seamlessly with the Qaelum software, providing improved information without extra effort on the part of the user. “We are thrilled to extend the use of our VirtualDose technology to Qaelum customers through this new partnership, and by doing this, improve patient safety in medical imaging worldwide” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc.   A display screen from the QAELUM DOSE software An example output from VirtualDoseCT ABOUT QAELUM N.V. QAELUM is a high-tech spin-off company of the University Hospitals Leuven. Based on more than 15 years of quality assurance experience in an academic environment as well as in the field, QAELUM is considered as the preferred partner when it comes to medical imaging quality control. Leading hospital groups share our vision of a global system for quality assurance, which realizes optimal use of radiation and guarantees maximum safety for patients and staff. At the same time, they acquire a more detailed overview of and deeper insights into all quality related aspects. Passionate about solving real world problems, QAELUM focuses on the development and deployment of highly innovative solutions and services to resolve the daily problems of every medical imaging professional. Ranging from automated quality control in nationwide breast screening programs to optimized solutions for local patient dose monitoring, QAELUM has solutions for all these problems regardless of the scale. The combination of advanced software tools and expert knowledge in the field, makes the innovative solutions offering a preferred choice for healthcare professionals. Jurgen Jacobs PDG E-mail: jurgen.jacobs@qaelum.com Gsm: +32 472 801293 Sofie Ignoul Marketing...

read more

Virtual Phantoms at RSNA 2016

Posted on Nov 9, 2016

Virtual Phantoms Chief Technology Officer, Dr. Peter F. Caracappa, will be at the Radiological Society of North America annual meeting in Chicago, IL on November 29 & 30, 2016.   If you would like to participate in a live demonstration of VirutalDoseCT, or discuss the VirtualDose system, contact peter.caracappa@virtualphantoms.com to schedule an appointment.  

read more

New VirtualDoseCT paper in Radiation Protection Dosimetry

Posted on Aug 5, 2016

A new evaluation of effective dose from CT scans using the VirutalDoseCT software has been released online prior to print publication by the Radiation Protection Dosimetry journal.   PubMed abstract Publisher link to full text

read more